메뉴 건너뛰기




Volumn 19, Issue 8, 2008, Pages 1379-1386

Targeting Src in breast cancer

Author keywords

Breast cancer; Cancer drug development; Growth factors and receptors; Oncology metastasis; Src; Translational oncology signal transduction

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 6 (2,6 DICHLOROPHENYL) 8 METHYL 2 (3 METHYLTHIOANILINO) 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; 7 [4 [2 (2 METHOXYETHYLAMINO)ETHOXY]PHENYL] 5 (4 METHOXYPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 AMINE; ANTINEOPLASTIC AGENT; AP 22161; AP 22408; AP 23451; AP 23588; BEVACIZUMAB; BOSUTINIB; CGP 77675; DASATINIB; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERLOTINIB; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; GEFITINIB; LAPATINIB; MITOGEN ACTIVATED PROTEIN KINASE; N (5 CHLORO 1,3 BENZODIOXOL 4 YL) 7 [2 (4 METHYL 1 PIPERAZINYL)ETHOXY] 5 (TETRAHYDRO 2H PYRAN 4 YLOXY) 4 QUINAZOLINAMINE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; STAT3 PROTEIN; SUNITINIB; TAMOXIFEN; TRASTUZUMAB; UC 15A; UNINDEXED DRUG; XL 999;

EID: 48749118203     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn291     Document Type: Review
Times cited : (213)

References (73)
  • 1
    • 33751530274 scopus 로고    scopus 로고
    • Steroid receptors and their role in the biology and control of breast cancer growth
    • Cordera F, Jordan VC. Steroid receptors and their role in the biology and control of breast cancer growth. Semin Oncol 2006; 33: 631-641.
    • (2006) Semin Oncol , vol.33 , pp. 631-641
    • Cordera, F.1    Jordan, V.C.2
  • 2
    • 37049183697 scopus 로고
    • Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
    • Slamon DJ, Clark GM, Wong SG et al. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177-182.
    • (1987) Science , vol.235 , pp. 177-182
    • Slamon, D.J.1    Clark, G.M.2    Wong, S.G.3
  • 3
    • 0035869407 scopus 로고    scopus 로고
    • Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
    • Slamon DJ, Leyland-Jones B, Shak S et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344: 783-792.
    • (2001) N Engl J Med , vol.344 , pp. 783-792
    • Slamon, D.J.1    Leyland-Jones, B.2    Shak, S.3
  • 4
    • 33847136743 scopus 로고    scopus 로고
    • Triple-negative breast cancer: Therapeutic options
    • Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol 2007; 8: 235-244.
    • (2007) Lancet Oncol , vol.8 , pp. 235-244
    • Cleator, S.1    Heller, W.2    Coombes, R.C.3
  • 5
    • 0034680102 scopus 로고    scopus 로고
    • Molecular portraits of human breast tumours
    • Perou CM, Sorlie T, Elsen MB et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-752.
    • (2000) Nature , vol.406 , pp. 747-752
    • Perou, C.M.1    Sorlie, T.2    Elsen, M.B.3
  • 6
    • 0035845511 scopus 로고    scopus 로고
    • Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
    • Sorlie T, Perou CM, Tibshirani R et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869-10874.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 10869-10874
    • Sorlie, T.1    Perou, C.M.2    Tibshirani, R.3
  • 7
    • 0042838307 scopus 로고    scopus 로고
    • Breast cancer classification and prognosis based on gene expression profiles from a population-based study
    • Sotiriou C, Neo SY, McShane LM et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003; 100: 10393-10398.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 10393-10398
    • Sotiriou, C.1    Neo, S.Y.2    McShane, L.M.3
  • 8
    • 0038386613 scopus 로고    scopus 로고
    • Src family kinases in tumor progression and metastasis
    • Summy JM, Gallick GE. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 2003; 22: 337-358.
    • (2003) Cancer Metastasis Rev , vol.22 , pp. 337-358
    • Summy, J.M.1    Gallick, G.E.2
  • 9
    • 2942618768 scopus 로고    scopus 로고
    • A renaissance for SRC
    • Yeatman TJ. A renaissance for SRC. Nat Rev Cancer 2004; 4: 470-480.
    • (2004) Nat Rev Cancer , vol.4 , pp. 470-480
    • Yeatman, T.J.1
  • 10
    • 0000374583 scopus 로고
    • Overexpression of the c-SRC protein does not induce transformation of NH3T3 cells
    • Shalloway D, Coussens PM, Yacíuk P. Overexpression of the c-SRC protein does not induce transformation of NH3T3 cells. Proc Natl Acad Sci USA 1984; 81: 7071-7075.
    • (1984) Proc Natl Acad Sci USA , vol.81 , pp. 7071-7075
    • Shalloway, D.1    Coussens, P.M.2    Yacíuk, P.3
  • 11
    • 0031439247 scopus 로고    scopus 로고
    • Cellular functions regulated by Src family kinases
    • Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997; 13: 513-609.
    • (1997) Annu Rev Cell Dev Biol , vol.13 , pp. 513-609
    • Thomas, S.M.1    Brugge, J.S.2
  • 12
    • 17444374230 scopus 로고    scopus 로고
    • Src kinase regulation by phosphorylation and dephosphorylation
    • Roskoski R Jr. Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 2005; 331: 1-14.
    • (2005) Biochem Biophys Res Commun , vol.331 , pp. 1-14
    • Roskoski Jr., R.1
  • 13
    • 34248397608 scopus 로고    scopus 로고
    • Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells
    • Chou MT, Wang J, Fujita DJ. Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells. BMC Biochem 2002; 3: 32.
    • (2002) BMC Biochem , vol.3 , pp. 32
    • Chou, M.T.1    Wang, J.2    Fujita, D.J.3
  • 14
    • 0036241054 scopus 로고    scopus 로고
    • EphrinB phosphorylation and reverse signaling: Regulation by Src kinases and PTP-BL phosphatase
    • Palmer A, Zimmer M, Erdmann KS et al. EphrinB phosphorylation and reverse signaling: Regulation by Src kinases and PTP-BL phosphatase. Mol Cell 2002; 9: 725-737.
    • (2002) Mol Cell , vol.9 , pp. 725-737
    • Palmer, A.1    Zimmer, M.2    Erdmann, K.S.3
  • 15
    • 0020645860 scopus 로고
    • Expression of pp60c-src protein Wase in adult and fetal human tissue: High activities in some sarcomas and mammary carcinomas
    • Jacobs C, Rubsamen H. Expression of pp60c-src protein Wase in adult and fetal human tissue: High activities in some sarcomas and mammary carcinomas. Cancer Res 1983; 43: 1696-1702.
    • (1983) Cancer Res , vol.43 , pp. 1696-1702
    • Jacobs, C.1    Rubsamen, H.2
  • 16
    • 0026674221 scopus 로고
    • Characterization of protein tyrosine kinases from human breast cancer: Involvement of the c-src oncogene product
    • Ottenhoff-Kalff AE, Rijksen G, van Beurden EA et al. Characterization of protein tyrosine kinases from human breast cancer: Involvement of the c-src oncogene product. Cancer Res 1992; 52: 4773-4778.
    • (1992) Cancer Res , vol.52 , pp. 4773-4778
    • Ottenhoff-Kalff, A.E.1    Rijksen, G.2    van Beurden, E.A.3
  • 17
    • 0031979414 scopus 로고    scopus 로고
    • Characterization of human epidermal growth factor receptor and c-Src interactions in human break tumor cells
    • Biscardi JS, Belsches AP, Parsons SJ. Characterization of human epidermal growth factor receptor and c-Src interactions in human break tumor cells. Mol Carcinog 1998; 21: 261-272.
    • (1998) Mol Carcinog , vol.21 , pp. 261-272
    • Biscardi, J.S.1    Belsches, A.P.2    Parsons, S.J.3
  • 18
    • 0030474489 scopus 로고    scopus 로고
    • c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis
    • Verbeek BS, Vroom TM, Driaansen-Slot SS et al. c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 1996; 180: 383-388.
    • (1996) J Pathol , vol.180 , pp. 383-388
    • Verbeek, B.S.1    Vroom, T.M.2    Driaansen-Slot, S.S.3
  • 19
    • 8344223854 scopus 로고    scopus 로고
    • Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: Implications for cell proliferation
    • Shupnik MA. Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: Implications for cell proliferation. Oncogene 2004; 23: 7979-7989.
    • (2004) Oncogene , vol.23 , pp. 7979-7989
    • Shupnik, M.A.1
  • 20
    • 24644510849 scopus 로고    scopus 로고
    • c-Src-null mice exhibit defects in normal mammary gland development and ER-alpha signalling
    • Kim H, Laing M, Muller W. c-Src-null mice exhibit defects in normal mammary gland development and ER-alpha signalling. Oncogene 2005; 24: 5629-5636.
    • (2005) Oncogene , vol.24 , pp. 5629-5636
    • Kim, H.1    Laing, M.2    Muller, W.3
  • 21
    • 3142511046 scopus 로고    scopus 로고
    • Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones
    • Boonyaratanakornkit V, Edwards DP. Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones. Essays Biochem 2004; 40: 105-120.
    • (2004) Essays Biochem , vol.40 , pp. 105-120
    • Boonyaratanakornkit, V.1    Edwards, D.P.2
  • 22
    • 33846235881 scopus 로고    scopus 로고
    • Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells
    • Herynk MH, Beyer AR, Cui Y et al. Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells. Mol Cancer Ther 2006; 5: 3023-3031.
    • (2006) Mol Cancer Ther , vol.5 , pp. 3023-3031
    • Herynk, M.H.1    Beyer, A.R.2    Cui, Y.3
  • 23
    • 33749316418 scopus 로고    scopus 로고
    • The epidermal growth factor receptor pathway: A model for targeted therapy
    • Scaltriti M, Baselga J. The epidermal growth factor receptor pathway: A model for targeted therapy. Clin Cancer Res 2006; 12: 5268-5272.
    • (2006) Clin Cancer Res , vol.12 , pp. 5268-5272
    • Scaltriti, M.1    Baselga, J.2
  • 24
    • 0029121267 scopus 로고
    • Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: Implications for the etiology of multiple human cancers
    • Maa MC, Leu TH, McCarley DJ et al. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: Implications for the etiology of multiple human cancers. Proc Nat Acad Sci USA 1995; 92: 6981-6985.
    • (1995) Proc Nat Acad Sci USA , vol.92 , pp. 6981-6985
    • Maa, M.C.1    Leu, T.H.2    McCarley, D.J.3
  • 25
    • 0023675030 scopus 로고
    • Augmented mitogenic responsiveness to epidermal growth factor in murine fibroblasts that overexpress pp60c-src
    • Luttrell DK, Luttrell LM, Parsons SJ. Augmented mitogenic responsiveness to epidermal growth factor in murine fibroblasts that overexpress pp60c-src. Mot Cell Biol 1988; 8: 497-501.
    • (1988) Mot Cell Biol , vol.8 , pp. 497-501
    • Luttrell, D.K.1    Luttrell, L.M.2    Parsons, S.J.3
  • 26
    • 0024478058 scopus 로고
    • pp6oc-src tyrosine kinase, myristylation, and modulatory domains are required for enhanced mitogenic responsiveness to epidermal growth factor seen in cells overexpressing c-src
    • Wilson LK, Luttrell DK, Parsons JT Parsons SJ. pp6oc-src tyrosine kinase, myristylation, and modulatory domains are required for enhanced mitogenic responsiveness to epidermal growth factor seen in cells overexpressing c-src. Mol Cell Biol 1989; 9: 1636-1544.
    • (1989) Mol Cell Biol , vol.9 , pp. 1636-1544
    • Wilson, L.K.1    Luttrell, D.K.2    Parsons, J.T.3    Parsons, S.J.4
  • 27
    • 0035399133 scopus 로고    scopus 로고
    • An essential role for Src kinase in ErbB receptor signaling through the MAPK pathway
    • Olayioye MA, Badache A, Daly JM, Hynes NE. An essential role for Src kinase in ErbB receptor signaling through the MAPK pathway. Exp Cell Res 2001; 267: 81-87.
    • (2001) Exp Cell Res , vol.267 , pp. 81-87
    • Olayioye, M.A.1    Badache, A.2    Daly, J.M.3    Hynes, N.E.4
  • 28
    • 0033546315 scopus 로고    scopus 로고
    • ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases
    • Olayioye MA, Beuvink I, Horsch K et al. ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases. J Biol Chem 1999; 274: 17209-17218.
    • (1999) J Biol Chem , vol.274 , pp. 17209-17218
    • Olayioye, M.A.1    Beuvink, I.2    Horsch, K.3
  • 29
    • 0035799531 scopus 로고    scopus 로고
    • Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
    • Garcia R, Bowman TL, Niu G et al. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 2001; 20: 2499-2513.
    • (2001) Oncogene , vol.20 , pp. 2499-2513
    • Garcia, R.1    Bowman, T.L.2    Niu, G.3
  • 30
    • 33745402375 scopus 로고    scopus 로고
    • Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
    • Hiscox S, Morgan L, Green TP et al. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells. Breast Cancer Res Treat 2006; 97: 263-274.
    • (2006) Breast Cancer Res Treat , vol.97 , pp. 263-274
    • Hiscox, S.1    Morgan, L.2    Green, T.P.3
  • 31
    • 34249326610 scopus 로고    scopus 로고
    • c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function
    • Ishizawar RC, Miyake T, Parsons SJ. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function. Oncogene 2007; 26: 3503-3510.
    • (2007) Oncogene , vol.26 , pp. 3503-3510
    • Ishizawar, R.C.1    Miyake, T.2    Parsons, S.J.3
  • 32
    • 0036674501 scopus 로고    scopus 로고
    • Dissemination and growth of cancer cells in metastatic sites
    • Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-572.
    • (2002) Nat Rev Cancer , vol.2 , pp. 563-572
    • Chambers, A.F.1    Groom, A.C.2    MacDonald, I.C.3
  • 33
    • 24644471128 scopus 로고    scopus 로고
    • c and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition
    • Avizienyte E, Frame MC, Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol 2005; 17: 542-547.
    • (2005) Curr Opin Cell Biol , vol.17 , pp. 542-547
    • Avizienyte, E.1    Frame Sr, M.C.2
  • 34
    • 2542561964 scopus 로고    scopus 로고
    • Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    • Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.
    • (2004) N Engl J Med , vol.350 , pp. 2335-2342
    • Hurwitz, H.1    Fehrenbacher, L.2    Novotny, W.3
  • 35
    • 33645364706 scopus 로고    scopus 로고
    • Phase II study of SU11248, a multitargeted receptor tyrosine kinase inhibitor (TKI), in patients (pts) with previously treated metastatic breast cancer (MBC) [abstract]
    • 19s
    • Miller KD, Burstein HJ, Elias HID et al. Phase II study of SU11248, a multitargeted receptor tyrosine kinase inhibitor (TKI), in patients (pts) with previously treated metastatic breast cancer (MBC) [abstract]. J Clin Oncol 2005; 23: 19s.
    • (2005) J Clin Oncol , vol.23
    • Miller, K.D.1    Burstein, H.J.2    Elias, H.I.D.3
  • 36
    • 0029068339 scopus 로고
    • Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation
    • Mukhopadhyay D, Tsiokas L, Zhou XM et al. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 1995; 375: 577-581.
    • (1995) Nature , vol.375 , pp. 577-581
    • Mukhopadhyay, D.1    Tsiokas, L.2    Zhou, X.M.3
  • 37
    • 0035884402 scopus 로고    scopus 로고
    • Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/ VEGF) expression in mammary carcinoma
    • Pal S, Datta K, Mukhopadhyay D. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/ VEGF) expression in mammary carcinoma. Cancer Res 2001; 61: 6952-6957.
    • (2001) Cancer Res , vol.61 , pp. 6952-6957
    • Pal, S.1    Datta, K.2    Mukhopadhyay, D.3
  • 38
    • 33744936606 scopus 로고    scopus 로고
    • Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors
    • Tan M, Li P, Sun M et al. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors. Oncogene, 2006; 25: 3286-3295.
    • (2006) Oncogene , vol.25 , pp. 3286-3295
    • Tan, M.1    Li, P.2    Sun, M.3
  • 39
    • 33746342801 scopus 로고    scopus 로고
    • Role of c-Src in human MCF7 breast cancer cell tumorigenesis
    • Gonzalez L, Gullo-Ortuno MT, Garcia-Martinez JM et al. Role of c-Src in human MCF7 breast cancer cell tumorigenesis. J Biol Chem 2006; 281: 20851-20864.
    • (2006) J Biol Chem , vol.281 , pp. 20851-20864
    • Gonzalez, L.1    Gullo-Ortuno, M.T.2    Garcia-Martinez, J.M.3
  • 40
    • 0034686024 scopus 로고    scopus 로고
    • Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells
    • Gutwein P, Oleszewski M, Mechtersheimer S et al. Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells. J Biol Chem 2000; 275: 15490-15497.
    • (2000) J Biol Chem , vol.275 , pp. 15490-15497
    • Gutwein, P.1    Oleszewski, M.2    Mechtersheimer, S.3
  • 41
    • 31544460437 scopus 로고    scopus 로고
    • Activation of stat3 in primary tumors f rorn high-risk breast cancer patients is associated with elevated levels at activated SRC and survivin expression
    • Diaz N, Minton S, Cox C et al. Activation of stat3 in primary tumors f rorn high-risk breast cancer patients is associated with elevated levels at activated SRC and survivin expression. Clin Cancer Res 2006; 12: 20-28.
    • (2006) Clin Cancer Res , vol.12 , pp. 20-28
    • Diaz, N.1    Minton, S.2    Cox, C.3
  • 42
    • 0026023289 scopus 로고
    • Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
    • Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991; 64: 693-702.
    • (1991) Cell , vol.64 , pp. 693-702
    • Soriano, P.1    Montgomery, C.2    Geske, R.3    Bradley, A.4
  • 43
    • 0026612467 scopus 로고
    • Requirement at pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice
    • Boyce BF, Yoneda T, Lowe C et al. Requirement at pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 1992; 90: 1622-1627.
    • (1992) J Clin Invest , vol.90 , pp. 1622-1627
    • Boyce, B.F.1    Yoneda, T.2    Lowe, C.3
  • 44
    • 0035825121 scopus 로고    scopus 로고
    • Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility
    • Sanjay A, Houghton A, Neff L et al. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol 2001; 152: 181-195.
    • (2001) J Cell Biol , vol.152 , pp. 181-195
    • Sanjay, A.1    Houghton, A.2    Neff, L.3
  • 45
    • 0041513490 scopus 로고    scopus 로고
    • C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis
    • Myoui A, Nishimura R, Williams PJ et al. C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res 2003; 63: 5028-5033.
    • (2003) Cancer Res , vol.63 , pp. 5028-5033
    • Myoui, A.1    Nishimura, R.2    Williams, P.J.3
  • 46
    • 0028333974 scopus 로고
    • Parathyroid hormone-related peptide is a downstream target for ras and src activation
    • Li X, Drucker DJ. Parathyroid hormone-related peptide is a downstream target for ras and src activation. J Biol Chem 1994; 269: 6263-6266.
    • (1994) J Biol Chem , vol.269 , pp. 6263-6266
    • Li, X.1    Drucker, D.J.2
  • 47
    • 0034676060 scopus 로고    scopus 로고
    • Decreased c-Src: Expression enhances osteololast differentiation and bone formation
    • Marzia M, Sims NA, Voït S et al. Decreased c-Src: Expression enhances osteololast differentiation and bone formation. J Cell Biol 2000; 151: 311-320.
    • (2000) J Cell Biol , vol.151 , pp. 311-320
    • Marzia, M.1    Sims, N.A.2    Voït, S.3
  • 48
    • 17344380187 scopus 로고    scopus 로고
    • A Src SH2 selective binding compound inhibits osteoclast-mediated resorption
    • Violette SM, Shakespeare WC, Bartlett C et al. A Src SH2 selective binding compound inhibits osteoclast-mediated resorption. Chem Biol 2000; 7: 225-235.
    • (2000) Chem Biol , vol.7 , pp. 225-235
    • Violette, S.M.1    Shakespeare, W.C.2    Bartlett, C.3
  • 49
    • 33744813556 scopus 로고    scopus 로고
    • Genes associated with breast cancer metastatic to bone
    • Smid M, Wang Y, Klijn JG et al. Genes associated with breast cancer metastatic to bone. J Clin Oncol 2006; 24: 2261-2267.
    • (2006) J Clin Oncol , vol.24 , pp. 2261-2267
    • Smid, M.1    Wang, Y.2    Klijn, J.G.3
  • 50
    • 0038488950 scopus 로고    scopus 로고
    • A multigenic program mediating breast cancer metastasis to bone
    • Kang Y, Siegel PM, Shu W et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003; 3: 537-549.
    • (2003) Cancer Cell , vol.3 , pp. 537-549
    • Kang, Y.1    Siegel, P.M.2    Shu, W.3
  • 51
    • 25144517586 scopus 로고    scopus 로고
    • Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab
    • Mass RD, Press MF, Anderson S et al. Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab. Clin Breast, Cancer 2005; 6: 240-246.
    • (2005) Clin Breast, Cancer , vol.6 , pp. 240-246
    • Mass, R.D.1    Press, M.F.2    Anderson, S.3
  • 53
    • 33744960226 scopus 로고    scopus 로고
    • Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
    • Carey LA, Perou CM, Livasy CA et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295: 2492-2502.
    • (2006) JAMA , vol.295 , pp. 2492-2502
    • Carey, L.A.1    Perou, C.M.2    Livasy, C.A.3
  • 54
    • 34548701082 scopus 로고    scopus 로고
    • Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/ 'triple-negative' breast cancer cell lines growing in vitro
    • Finn IRS, Dering J, Ginther C et al. Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/ 'triple-negative' breast cancer cell lines growing in vitro. Breast Cancer Res Treat 2007; 105: 319-326.
    • (2007) Breast Cancer Res Treat , vol.105 , pp. 319-326
    • Finn, I.R.S.1    Dering, J.2    Ginther, C.3
  • 55
    • 33947225176 scopus 로고    scopus 로고
    • Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: Rationale for patient selection
    • Huang F, Reeves K, Han K et al. Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: Rationale for patient selection. Cancer Res 2007; 67: 2226-2238.
    • (2007) Cancer Res , vol.67 , pp. 2226-2238
    • Huang, F.1    Reeves, K.2    Han, K.3
  • 56
    • 19944428353 scopus 로고    scopus 로고
    • Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2- methylpyrimidin-4-ylamino)-thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays
    • Lombardo LJ, Lee FY, Chen P et al. Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2- methylpyrimidin-4-ylamino)-thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J Med Chem 2004; 47: 6658-6661.
    • (2004) J Med Chem , vol.47 , pp. 6658-6661
    • Lombardo, L.J.1    Lee, F.Y.2    Chen, P.3
  • 57
    • 26444468152 scopus 로고    scopus 로고
    • Dasatinib (BMS-3548285) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoplosis of head and neck squamous cell carcinoma and non-small cell lung cancer cell
    • Johnson FM, Saigal B, Talpaz M, Donato NJ. Dasatinib (BMS-3548285) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoplosis of head and neck squamous cell carcinoma and non-small cell lung cancer cell. Clin Cancer Res 2005, 11: 6924-6932.
    • (2005) Clin Cancer Res , vol.11 , pp. 6924-6932
    • Johnson, F.M.1    Saigal, B.2    Talpaz, M.3    Donato, N.J.4
  • 58
    • 33745243692 scopus 로고    scopus 로고
    • Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival
    • Song L, Morris M, Bagui T et al. Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. Cancer Res 2006; 66: 5542-5548.
    • (2006) Cancer Res , vol.66 , pp. 5542-5548
    • Song, L.1    Morris, M.2    Bagui, T.3
  • 59
    • 33644647192 scopus 로고    scopus 로고
    • Inhibition of Src expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model
    • Trevino A Summy JM, Lesslie DP et al. Inhibition of Src expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am J Pathol 2006; 168: 962-972.
    • (2006) Am J Pathol , vol.168 , pp. 962-972
    • Trevino, A.1    Summy, J.M.2    Lesslie, D.P.3
  • 60
    • 29144492198 scopus 로고    scopus 로고
    • BMS-354825 potently inhibits multiple selected oncogenic tyrosine kinases and possesses broad-spectrum antitumor activities in vitro and in vivo [abstract]
    • Lee FY, Lombardo L, Camuso A et al. BMS-354825 potently inhibits multiple selected oncogenic tyrosine kinases and possesses broad-spectrum antitumor activities in vitro and in vivo [abstract]. Proc Am Assoc Cancer Res 2005; 46: 159.
    • (2005) Proc Am Assoc Cancer Res , vol.46 , pp. 159
    • Lee, F.Y.1    Lombardo, L.2    Camuso, A.3
  • 61
    • 33846226773 scopus 로고    scopus 로고
    • Dasatinib (BMS-354825) pharmacokinetics correlate with pSRC pharmacodynamics in phase I studies of patients with cancer (CA180002, CA180003) [abstract]
    • 132s
    • Luo FR, Barrett Y, Ji P et al. Dasatinib (BMS-354825) pharmacokinetics correlate with pSRC pharmacodynamics in phase I studies of patients with cancer (CA180002, CA180003) [abstract]. J Clin Oncol 2006; 24: 132s.
    • (2006) J Clin Oncol , vol.24
    • Luo, F.R.1    Barrett, Y.2    Ji, P.3
  • 62
    • 33847728182 scopus 로고    scopus 로고
    • A Src/Abl kinase Inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo
    • Jallal H, Valentino ML, Chen G et al. A Src/Abl kinase Inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo. Cancer Res 2007; 67: 1580-1588.
    • (2007) Cancer Res , vol.67 , pp. 1580-1588
    • Jallal, H.1    Valentino, M.L.2    Chen, G.3
  • 63
    • 20444500171 scopus 로고    scopus 로고
    • SKJ-606, a Src/AbI inhibitor with in vivo activity in colon tumor xenograft models
    • Golas A Lucas J, Etienne C et al. SKJ-606, a Src/AbI inhibitor with in vivo activity in colon tumor xenograft models. Cancer Res 2005; 65: 5358-5364.
    • (2005) Cancer Res , vol.65 , pp. 5358-5364
    • Golas, A.1    Lucas, J.2    Etienne, C.3
  • 64
    • 48749101362 scopus 로고    scopus 로고
    • Hennequin LF, Allen J, Breed J et al
    • Hennequin LF, Allen J, Breed J et al.
  • 65
    • 34249776956 scopus 로고    scopus 로고
    • Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells
    • Hiscox S, Jordan NJ, Morgan L et al. Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells. Clin Exp Metastasis 2007; 24: 157-167.
    • (2007) Clin Exp Metastasis , vol.24 , pp. 157-167
    • Hiscox, S.1    Jordan, N.J.2    Morgan, L.3
  • 66
    • 33745928222 scopus 로고    scopus 로고
    • The effect of AZD0530, a highly selective, orally available SrclAbl kinase inhibitor, on biomarkers of bone resorption in healthy males [abstract]
    • 202s
    • Eastell R, Hannon RA, Gallagher N et al. The effect of AZD0530, a highly selective, orally available SrclAbl kinase inhibitor, on biomarkers of bone resorption in healthy males [abstract]. J Clin Oncol 2005; 23: 202s.
    • (2005) J Clin Oncol , vol.23
    • Eastell, R.1    Hannon, R.A.2    Gallagher, N.3
  • 67
    • 29144523093 scopus 로고    scopus 로고
    • Phase I ascending single and multiple dose studies to assess the safety, tolerability and pharmacokinetics of AZD0530, a highly selective, dual-specific Src-Abl inhibitor [abstract]
    • 223s
    • Lockton A Smethurst D, Macpherson M et al. Phase I ascending single and multiple dose studies to assess the safety, tolerability and pharmacokinetics of AZD0530, a highly selective, dual-specific Src-Abl inhibitor [abstract]. J Clin Oncol 2005; 23: 223s.
    • (2005) J Clin Oncol , vol.23
    • Lockton, A.1    Smethurst, D.2    Macpherson, M.3
  • 68
    • 29144435297 scopus 로고    scopus 로고
    • Inhibition of osteoclastic bone resorption by the novel, potent, and selective c-Src/Abl kinase inhibitor, AZD0530 [abstract)
    • Mullender MG, Everts V, Green TP. Inhibition of osteoclastic bone resorption by the novel, potent, and selective c-Src/Abl kinase inhibitor, AZD0530 [abstract). Proc Am Assoc Cancer Res 2005; 46: 686.
    • (2005) Proc Am Assoc Cancer Res , vol.46 , pp. 686
    • Mullender, M.G.1    Everts, V.2    Green, T.P.3
  • 69
    • 34748881947 scopus 로고    scopus 로고
    • Next generation molecular targeted agents for breast cancer: Focus on EGFR and VEGFR pathways
    • Hitake K, Tokudome N, Ito Y. Next generation molecular targeted agents for breast cancer: Focus on EGFR and VEGFR pathways. Breast Cancer 2007; 14: 132-149.
    • (2007) Breast Cancer , vol.14 , pp. 132-149
    • Hitake, K.1    Tokudome, N.2    Ito, Y.3
  • 70
    • 0037234153 scopus 로고    scopus 로고
    • Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells
    • Boudny V, Nakano S. Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells. Anticancer Res 2003; 23: 7-12.
    • (2003) Anticancer Res , vol.23 , pp. 7-12
    • Boudny, V.1    Nakano, S.2
  • 71
    • 8544272554 scopus 로고    scopus 로고
    • Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-Induced apoptosis
    • Griffiths GJ, Koh MY, Brunton VG et al. Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-Induced apoptosis. J Biol Chem 2004; 279: 46113-46121.
    • (2004) J Biol Chem , vol.279 , pp. 46113-46121
    • Griffiths, G.J.1    Koh, M.Y.2    Brunton, V.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.